Home / Expertise / Life Sciences & Healthcare

Life Sciences & Healthcare

Netherlands

We work for top 100 enterprise. For example farmaceutical companies ranked in the global top 20. Furthermore, nine out of ten of the global producers of medical instruments are part of our client base. To our lawyers – who often have an in-house history in your industry themselves – your industry has no secrets. The marketing of medicinal products. Public procurement. Pricing and reimbursement. The protection of patents. Or agreements for clinical trials. We know what you are talking about. That is why we assist our top clients with their strategic decisions, the structuring of their business transactions and in legal proceedings.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology and medical devices. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice. Equally, when you need lifesciences specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Read more Read less

‘Speedy responses and practical advice in pharma and corporate law matters.’

The Legal 500 EMEA, 2020

"really brilliant" , "broad network" and that the firm "co-ordinates things well".

Chambers Europe-wide, 2020

"Really efficient and quick."

Chambers Global, 2020

"The firm is a reliable international firm that has shown us a deep knowledge of the applicable law and significant practical experience on relevant cases."

Chambers Global, 2020

"Extremely responsive and overall always felt that I was in extremely safe hands."

Chambers Global, 2019

"They are very well connected with their team; they really use the benefit of working together in their various offices."

Chambers Global, 2019

A client describes the lawyers as "subject matter experts".

Chambers Europe, 2019

Clients praise the firm's international network as a key advantage, particularly appreciating that "it is able to provide expertise across multiple jurisdictions. This co-operation is done in a very expedient and uncomplicated manner."

Chambers Europe, 2019

"The CMS team offers a broad range of expertise including regulatory, IP, and competition."

The Legal 500, 2019

In M&A the firm has a good reputation for working in the hospitality, life sciences and oil and gas sectors.

IFLR1000, 2019

Choose area

    Pharmaceuticals

    Pharmaceutical and healthcare law focuses on all the special legislation and legal aspects to do with medicine provision, biotechnology and healthcare. Whether it concerns manufacturing, operations, licences, rates, quality, market regulation or care insurance, there is specific legislation for all these areas.

    Read more
    02/04/2019
    WLG Can­nabis Leg­al­iz­a­tion: Europe Up­date
    What is the status of can­nabis lib­er­al­iz­a­tion in the Neth­er­lands, Ger­many and Spain? Pan­el­ists El­len Gielen (CMS Neth­er­lands), Jörn Witt, Susanne Pech (both CMS Ger­many) and Juan Car­los Hernanz (Cuatreca­s­as, Spain) will give an up­date on their jur­isd
    Sub­scribe to Life Sci­ences & Health­care top­ics
    August 2020
    CMS Life Sci­ences & Health­care Glob­al Bro­chure
    With more than 300 law­yers, pat­ent at­tor­neys, sci­ent­ists and aca­dem­ics’ across CMS and the sup­port of the Life Sci­ences Asia-Pa­cific Net­work (LAN), we un­der­stand the sci­entif­ic and com­mer­cial as well as the leg­al im­per­at­ives af­fect­ing your life sci­en

    Feed

    Show only
    15 September 2020
    On the Pulse
    A video/pod­cast series, On the Pulse, brings to­geth­er CMS ex­perts to dis­cuss key top­ics im­pact­ing, in­nov­at­ing, dis­rupt­ing the life sci­ence & health­care sec­tor.
    20 April 2020
    CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
    Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
    14 September 2020
    An EPO Case Law Round-Up: Ad­ded Mat­ter
    The EPO is well-known for its strict ap­proach to as­sess­ing amend­ments un­der the ad­ded mat­ter pro­vi­sion of Art­icle 123 of the European Pat­ent Con­ven­tion. This of­ten cre­ates com­plex leg­al scen­ari­os which...
    07 July 2020
    CMS ad­vises Im­mat­ics on the busi­ness com­bin­a­tion with Arya Sci­ences Ac­quis­i­tion...
    20 April 2020
    CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
    Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
    13 August 2020
    Sus­tain­able food pro­gress may close glob­al reg­u­lat­ory gap
    In­nov­a­tion in the sus­tain­able food sec­tor is for­ging ahead at a re­mark­able pace. Our cur­rent food sources ac­count for nearly one-third of glob­al GHG emis­sions while con­sumers are in­creas­ingly bet­ter edu­cated...
    17 June 2020
    Pod­cast: Ad­vert­ising of Medi­cines and Med­ic­al Devices
    Epis­ode #2 of On the Pulse brought to you by the Glob­al Life Sci­ences & Health­care Sec­tor Group
    22 July 2020
    Around 1600 view­ers re­gister for live video stream of com­puter soft­ware...
    The En­larged Board of the European Pat­ent Of­fice re­cently heard or­al ar­gu­ments con­cern­ing pat­entab­il­ity of a com­puter soft­ware in­ven­tion. This rare event was video streamed to over 1600 pat­ent stake­hold­ers....
    04/05/2020
    5 mis­con­cep­tions about the GDPR data breach no­ti­fic­a­tion
    14 July 2020
    Santen ends Neur­im-style SPCs
    The word­ing of Art­icle 3(d) of the SPC Reg­u­la­tion re­quires that the SPC ap­plic­a­tion must rely on “the first au­thor­isa­tion to place the product on the mar­ket as a medi­cin­al product”. This sug­gests...
    20/03/2020
    CMS as­sists Dutch com­pany with the sale and dis­tri­bu­tion of ap­proved corona...
    08 July 2020
    “WIPO PROOF”: WIPO’s new on­line ser­vice which helps in­nov­at­ors and cre­at­ors...
    The World In­tel­lec­tu­al Prop­erty Or­gan­isa­tion (WIPO) re­cently launched its new on­line busi­ness ser­vice, “WIPO PROOF”. The plat­form aims to help in­nov­at­ors and cre­at­ors safe­guard their in­tel­lec­tu­al...